Canopy Growth Corp (WEED) - Total Assets

Latest as of December 2025: CA$1.11 Billion CAD ≈ $800.20 Million USD

Based on the latest financial reports, Canopy Growth Corp (WEED) holds total assets worth CA$1.11 Billion CAD (≈ $800.20 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Canopy Growth Corp (WEED) shareholders funds for net asset value and shareholders' equity analysis.

Canopy Growth Corp - Total Assets Trend (2010–2025)

This chart illustrates how Canopy Growth Corp's total assets have evolved over time, based on quarterly financial data.

Canopy Growth Corp - Asset Composition Analysis

Current Asset Composition (March 2025)

Canopy Growth Corp's total assets of CA$1.11 Billion consist of 32.1% current assets and 67.9% non-current assets.

Asset Category Amount (CAD) % of Total Assets
Cash & Equivalents CA$130.00K 12.4%
Accounts Receivable CA$52.78 Million 5.8%
Inventory CA$96.37 Million 10.5%
Property, Plant & Equipment CA$293.52 Million 32.0%
Intangible Assets CA$87.20 Million 9.5%
Goodwill CA$46.04 Million 5.0%

Asset Composition Trend (2010–2025)

This chart illustrates how Canopy Growth Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see how much is Canopy Growth Corp worth.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Canopy Growth Corp's current assets represent 32.1% of total assets in 2025, a decrease from 100.0% in 2010.
  • Cash Position: Cash and equivalents constituted 12.4% of total assets in 2025, up from 6.5% in 2010.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 14.0% of total assets, an increase from 0.0% in 2010.
  • Asset Diversification: The largest asset category is property, plant & equipment at 32.0% of total assets.

Canopy Growth Corp Competitors by Total Assets

Key competitors of Canopy Growth Corp based on total assets are shown below.

Company Country Total Assets
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
USA $15.42 Trillion
Regencell Bioscience Holdings Ltd
NASDAQ:RGC
USA $5.76 Million
Changchun High & New Technology Industries Group Inc
SHE:000661
China CN¥31.46 Billion
Yuhan Corp.
KO:000100
Korea ₩3.05 Trillion
Tonghua Dongbao Pharmaceutical Co Ltd
SHG:600867
China CN¥8.15 Billion
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
China CN¥19.57 Billion
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
China CN¥5.17 Billion
Guobang Pharma Ltd
SHG:605507
China CN¥10.58 Billion

Canopy Growth Corp - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 5.34 3.52 9.98
Quick Ratio 4.26 2.58 8.69
Cash Ratio 1.72 0.17 0.00
Working Capital CA$426.37 Million CA$244.07 Million CA$2.55 Billion

Canopy Growth Corp - Advanced Valuation Insights

This section examines the relationship between Canopy Growth Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 0.74
Latest Market Cap to Assets Ratio 0.45
Asset Growth Rate (YoY) -29.4%
Total Assets CA$917.70 Million
Market Capitalization $415.48 Million USD

Valuation Analysis

Below Book Valuation: The market values Canopy Growth Corp's assets below their book value (0.45x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Canopy Growth Corp's assets decreased by 29.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Canopy Growth Corp (2010–2025)

The table below shows the annual total assets of Canopy Growth Corp from 2010 to 2025.

Year Total Assets Change
2025-03-31 CA$917.70 Million
≈ $663.85 Million
-29.43%
2024-03-31 CA$1.30 Billion
≈ $940.64 Million
-46.69%
2023-03-31 CA$2.44 Billion
≈ $1.76 Billion
-56.56%
2022-03-31 CA$5.62 Billion
≈ $4.06 Billion
-17.71%
2021-03-31 CA$6.82 Billion
≈ $4.94 Billion
-0.50%
2020-03-31 CA$6.86 Billion
≈ $4.96 Billion
-21.46%
2019-03-31 CA$8.73 Billion
≈ $6.32 Billion
+507.72%
2018-03-31 CA$1.44 Billion
≈ $1.04 Billion
+112.04%
2017-03-31 CA$677.61 Million
≈ $490.17 Million
+372.66%
2016-03-31 CA$143.36 Million
≈ $103.71 Million
+452.19%
2015-03-31 CA$25.96 Million
≈ $18.78 Million
0.00%
2014-12-31 CA$25.96 Million
≈ $18.78 Million
+403.78%
2014-03-31 CA$5.15 Million
≈ $3.73 Million
+914.83%
2013-03-31 CA$507.81K
≈ $367.34K
-6.88%
2012-03-31 CA$545.35K
≈ $394.49K
-3.17%
2011-03-31 CA$563.21K
≈ $407.42K
-4.26%
2010-03-31 CA$588.30K
≈ $425.57K
--

About Canopy Growth Corp

TO:WEED Canada Drug Manufacturers - Specialty & Generic
Market Cap
$415.48 Million
CA$574.35 Million CAD
Market Cap Rank
#13495 Global
#388 in Canada
Share Price
CA$1.52
Change (1 day)
+0.66%
52-Week Range
CA$1.20 - CA$2.69
All Time High
CA$737.50
About

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia. It operates through four segments: Canada Cannabis, International Markets Cannabis, and Storz & Bickel, and This Works. The company offers dried flower and pre-rolled joints; extracts and concentrates, such… Read more